Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TIS”

109 trials

Showing 20 of 109 results

Post-approval studies (Phase 4)Study completedNCT02285075
What this trial is testing

Temocillin Pharmacokinetic in Hemodialysis

Who this might be right for
Gram-Negative Bacterial InfectionsRenal Failure Chronic Requiring Hemodialysis
AZ Sint-Jan AV 16
Early research (Phase 1)Study completedNCT01061814
What this trial is testing

Evaluate 3 Different Dosing Regimens of Mipomersen Administered Via Subcutaneous Injections to Healthy Volunteers

Who this might be right for
Healthy Volunteer
Kastle Therapeutics, LLC 84
Not applicableStudy completedNCT03284970
What this trial is testing

Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 34
Not applicableStudy completedNCT07059143
What this trial is testing

6 Weeks Right-Amygdala TIS for Depression

Who this might be right for
Major Depressive Disorder (MDD)
Ruijin Hospital 38
Testing effectiveness (Phase 2)Study completedNCT02415985
What this trial is testing

Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly

Who this might be right for
HIVTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Large-scale testing (Phase 3)Study completedNCT03033121
What this trial is testing

Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children

Who this might be right for
Growth Hormone Treatment
University of Palermo 32
Early research (Phase 1)Study completedNCT04671030
What this trial is testing

Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI

Who this might be right for
Spinal Cord InjuriesConstipationNeurogenic Bowel
James J. Peters Veterans Affairs Medical Center 6
Early research (Phase 1)Study completedNCT00741234
What this trial is testing

A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine

Who this might be right for
Solid TumorsHematologic MalignanciesMyelodysplastic Syndrome
S*BIO 85
Not applicableNot Yet RecruitingNCT07821788
What this trial is testing

Twice vs Thrice Weekly Hemodialysis: Clinical Outcomes and Quality of Life

Who this might be right for
Kidney Failure, ChronicQuality of Life
Assiut University 130
Large-scale testing (Phase 3)Not Yet RecruitingNCT07565701
What this trial is testing

Safety and Efficacy of a Phased Transition From Epogen to Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Subjects Receiving In-Center Hemodialysis

Who this might be right for
Anemia Associated With Chronic Kidney Disease
Geoff Block 100
Large-scale testing (Phase 3)Study completedNCT01076647
What this trial is testing

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 467
Testing effectiveness (Phase 2)Active Not RecruitingNCT00761618
What this trial is testing

Intrapleural Catheter Daily Versus Three Times a Week Drainage

Who this might be right for
Advanced CancerPleural Effusion
M.D. Anderson Cancer Center 257
Post-approval studies (Phase 4)Study completedNCT01085318
What this trial is testing

Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial

Who this might be right for
Multiple Sclerosis
EMD Serono 38
Not applicableStudy completedNCT02308670
What this trial is testing

Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University at Buffalo 150
Testing effectiveness (Phase 2)Study completedNCT00023283
What this trial is testing

Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

Who this might be right for
Heroin DependenceOpioid-Related DisordersSubstance Abuse, Intravenous
Yale University
Not applicableNot Yet RecruitingNCT07480382
What this trial is testing

Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC

Who this might be right for
Initially Unresectable Hepatocellular Carcinoma
Hong Wu 30
Post-approval studies (Phase 4)Study completedNCT01844778
What this trial is testing

Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI)

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals 60
Large-scale testing (Phase 3)Study completedNCT00048451
What this trial is testing

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

Who this might be right for
Renal Insufficiency, Chronic
Abbott 68
Not applicableWithdrawnNCT01460849
What this trial is testing

Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study Centers

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01036165
What this trial is testing

A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study

Who this might be right for
Multiple Sclerosis
EMD Serono 103
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation